Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2023-06-05 Regulatory Filings
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Pacific Edge Limited (“PEB”) – Trading Halt of Securities
Regulatory Filings Classification · 95% confidence The document is a memorandum from NZX Limited announcing a trading halt on Pacific Edge Limited's securities at the issuer's request. It mentions the halt was placed and is expected to be lifted after a material announcement. There is no financial data, report, or detailed disclosure here, only a regulatory announcement about trading status. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2023-06-05 English
Pacific Edge Trading Halt 2 pages 114.9KB
Regulatory Filings Classification · 95% confidence The document is a trading halt announcement by Pacific Edge regarding its shares on the NZX and ASX. It discusses the reason for the halt related to a Medicare reimbursement issue and mentions an upcoming announcement and conference call. The document is short (3257 characters) and does not contain financial statements, detailed financial data, or a full report. It is an operational update about trading status rather than a financial report or regulatory filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-06-05 English
Trading Halt 3 pages 344.0KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Pacific Edge Limited regarding a trading halt requested under ASX and NZX listing rules. It explains the reason for the halt is to allow the company time to assess a complex Medicare reimbursement determination before releasing an update. The document is short (3328 characters) and does not contain financial data or detailed report content. It is an announcement about a trading halt and an upcoming market update, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-04 English
Clarification of Novitas Timeline
Regulatory Filings Classification · 95% confidence The document is a clarification announcement regarding the timeline for the finalization or withdrawal of a draft Local Coverage Determination (LCD) and Local Coverage Article (LCA) related to Medicare reimbursement for a diagnostic test. It references a previous FY 23 results announcement but does not contain any financial statements, detailed financial data, or comprehensive report content. The document is relatively short (3211 characters) and serves as a market update or clarification rather than a full report or detailed filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings involving certifications. It is an announcement clarifying regulatory/timeline information related to Medicare coverage, which is best categorized under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-06-01 English
Clarification of Novitas Timeline 2 pages 113.7KB
Regulatory Filings Classification · 95% confidence The document is a clarification announcement regarding the timeline for a Medicare coverage determination related to Pacific Edge's Cxbladder tests. It references a previous FY 23 results announcement but does not contain any financial statements, detailed financial data, or comprehensive report content. The document is short (3211 characters) and serves as a market update or clarification rather than a full report or detailed filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings that require substantive financial or regulatory content. It is also not a report publication announcement since it does not mention the release or availability of a report. The content is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and market update that does not fit other specific categories.
2023-06-01 English
Pacific Edge Delivers on Growth Strategy in FY 2023
Annual Report Classification · 95% confidence The document is titled 'AUDITED FINANCIAL RESULTS FOR THE YEAR TO 31 MARCH 2023' and contains detailed financial and operational results for the full fiscal year ending March 31, 2023. It includes comprehensive financial performance data such as revenue, net loss, operating expenses, cash balances, and strategic highlights. The text discusses growth strategy, market expansion, product development, and outlook, which are typical components of an annual report. The length of the document (15,000 characters) and the depth of financial and operational detail confirm it is the full report rather than a brief announcement or summary. There is no indication that this is merely an announcement of a report or a certification letter. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2023-05-24 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.